AbbVie's Label Expansion, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
HCA Healthcare, Inc. (HCA)
Last hca healthcare, inc. earnings: 4/21 08:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.hcahealthcare.com
Company Research
Source: Seeking Alpha
SummaryAbbVie's Imbruvica gets a label expansion.Gilead's latest cancer collaborator is oNKo-Innate.HCA takes hospitals down after revenue miss.AbbVie Reports Label Expansion for ImbruvicaAbbVie (ABBVOTCQX:RHHBYJNJImbruvica works by controlling Bruton's tyrosine kinase, which is an enzyme responsible for oncogenic signaling. The drug's first approval came along in 2013 and it carved out a niche for itself in the market. The application for the latest approval was supported by the data from the E1912 study which tested the drug against the standard of care treatment of the chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab. It involved 529 patients who are previously untreated. The data showed that after 3 years, 89.4 percent of the patients in Imbruvica arm showed progression-free survival while the corresponding rate for the chemoimmunotherapy group was 72.9 percent.The overall survival rate was 98.8 percent and 91.5 percent respectively for the Imbruvica grou
Show less
Read more
Impact Snapshot
Event Time:
HCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCA alerts
High impacting HCA Healthcare, Inc. news events
Weekly update
A roundup of the hottest topics
HCA
News
- HCA names new chief nurse executive [Yahoo! Finance]Yahoo! Finance
- EndoQuest Receives FDA Approval to Initiate Final Stage of PARADIGM Trial [Yahoo! Finance]Yahoo! Finance
- HCA Healthcare Names Erica Rossitto as Chief Nurse Executive [Yahoo! Finance]Yahoo! Finance
- HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Leerink Partners from $470.00 to $507.00. They now have an "outperform" rating on the stock.MarketBeat
- L1 Capital International Strategy Trimmed HCA Healthcare (HCA) Due to Share Price Appreciation [Yahoo! Finance]Yahoo! Finance
HCA
Earnings
- 10/24/25 - Beat
HCA
Sec Filings
- 11/18/25 - Form 4
- 11/5/25 - Form 4
- 11/5/25 - Form 4
- HCA's page on the SEC website